PHARMACOMETRIC ANALYSIS SUPPORTS EARLY ONSET OF PROTECTION WITH GARADACIMAB AGAINST HEREDITARY ANGIOEDEMA ATTACKS

被引：0
作者：
Glassman, F.
Sharma, A.
Garcia, R.
Lawo, J.
Nenci, C.
Pragst, I.
Polhamus, D.
Puchalski, T.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2024年 / 133卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
R096
引用
收藏
页码：S32 / S32
页数：1
相关论文
共 50 条
  • [21] Garadacimab For Hereditary Angioedema Prophylaxis In Adolescents: Efficacy And Safety From The Phase 3 (VANGUARD) Study And Open-Label Extension (Second Interim Analysis)
    Jacobs, Joshua
    Magerl, Markus
    Martinez-Saguer, Inmaculada
    Li, Huamin
    Bernstein, Jonathan
    Hsu, Connie
    Sitz, Karl
    Wieman, Lolis
    Feuer-Senger, Henrike
    Pollen, Maressa
    Reshef, Avner
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB6 - AB6
  • [22] Patient Perspectives On Early Use Of Ondemand Treatment For Hereditary Angioedema (HAE) Attacks to Reduce Severity and Duration.
    Radojicic, Cristine
    Manning, Michael
    Guilarte, Mar
    Heckmann, Markus
    van Kooten, Sally
    Danese, Sherry
    Goga, Ledia
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB143 - AB143
  • [23] Early treatment with icatibant reduces the time to onset of symptom relief in children and adolescents with hereditary angioedema (HAE)
    Farkas, H.
    Ortega-Lopez, M. C.
    Reshef, A.
    Kessel, A.
    Caballero, T.
    Vardi, M.
    Hao, J.
    Aberer, W.
    ALLERGY, 2019, 74 : 210 - 211
  • [24] ForCES protocol design analysis for protection against DoS attacks
    Lakkavalli, S
    Khosravi, H
    ICCCN 2004: 13TH INTERNATIONAL CONFERENCE ON COMPUTER COMMUNICATIONS AND NETWORKS, PROCEEDINGS, 2004, : 550 - 550
  • [25] Hereditary angioedema: analysis of 287 attacks treated with C1 esterase inhibitor in the French cohort cobra
    Bouillet, L.
    Boccon-Gibod, I. A.
    Pagnier, A.
    Gompel, A.
    Floccard, B.
    Martin, L.
    Blanchard-Delaunay, C.
    Launay, D.
    Fain, O.
    Sobel, A.
    Gayet, S.
    Amarger, S.
    Armengol, G.
    Ollivier, Y.
    Zelinsky-Gurung, A.
    Jeandel, P.
    Kanny, G.
    Coppere, B.
    Dubrel, M.
    Pelletier, F.
    Du Thanh, A.
    Trouiller, S.
    Laurent, J.
    De Moreuil, C.
    Pajot, Audouin C.
    Belot, A.
    Allaert, F.
    ALLERGY, 2017, 72 : 593 - 593
  • [26] Combined efficacy analysis of recombinant human C1INH (rhC1INH) in the treatment of acute angioedema attacks in hereditary angioedema
    Pijpstra, R.
    Cicardi, M.
    Zuraw, B.
    Relan, A.
    Hack, E.
    Haase, G.
    Kaufman, L.
    Giannetti, B.
    ALLERGY, 2010, 65 : 13 - 13
  • [27] Garadacimab for hereditary angioedema prophylaxis: long term efficacy and safety from the Phase 3 VANGUARD trial and first interim analysis of the open-label extension trial
    Reshef, A.
    Magerl, M.
    Saguer, I. Martinez
    Bernstein, J. A.
    Farkas, H.
    Yang, W. H.
    Jacobs, J. S.
    Li, P. Hei
    Lumry, W. R.
    Aygoeren-Puersuen, E.
    Ohsawa, I.
    Katelaris, C.
    Longhurst, H.
    Hakl, R.
    Guilarte, M.
    Stroes, E. S. G.
    Feuersenger, H.
    Bica, M. A.
    Jacobs, I.
    Craig, T. J.
    ALLERGOLOGIE, 2023, 46 (08) : 561 - 562
  • [28] Online monitoring and analysis for self-protection against network attacks
    Qu, GZ
    Hariri, S
    Jangiti, S
    Rudraraju, J
    Oh, S
    Fayssal, S
    Zhang, GS
    Parashar, M
    INTERNATIONAL CONFERENCE ON AUTONOMIC COMPUTING, PROCEEDINGS, 2004, : 324 - 325
  • [29] Protection circuit against differential power analysis attacks for smart cards
    Muresan, Radu
    Gregori, Stefano
    IEEE TRANSACTIONS ON COMPUTERS, 2008, 57 (11) : 1540 - 1549
  • [30] Atlastin gene analysis in early onset hereditary spastic paraplegia.
    Alvarado, DM
    Ming, L
    Hedera, R
    Rainier, S
    Zhao, X
    Raskino, W
    Bird, T
    Fink, JK
    AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (04) : 597 - 597
12345